<p>First-line treatment of women with advanced ovarian cancer: focus on bevacizumab</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First-line treatment of women with advanced ovarian cancer: focus on bevacizumab

Published:2019-02 Issue: Volume:Volume 12 Page:1095-1103
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Marchetti Claudia,Muzii Ludovico,Romito Alessia,Benedetti Panici Pierluigi

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Niraparib as maintenance therapy in Japan: a retrospective observational study using a Japanese claims database;Journal of Gynecologic Oncology;2025

2. Comparative transcriptomic study on the ovarian cancer between chicken and human;Poultry Science;2024-09

3. Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and Europe;International Journal of Gynecologic Cancer;2024-08-20

4. The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities;Current Oncology;2024-07-01

5. Oncogenic Pathways and Targeted Therapies in Ovarian Cancer;Biomolecules;2024-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP